{
 "context": "The following article called 'BUZZ-Clovis Oncology's lung cancer drug can compete with AstraZeneca's - analysts' was published on 2015-09-09. The body of the article is as follows:\n    \nTerms \nQuotes are real-time for NASDAQ, NYSE, and NYSEAmex when available. See also delay times for other exchanges . Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page . Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. All information provided \"as is\" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. \nFundamental company data provided by Capital IQ . Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI) . International historical chart data and daily updates provided by Morningstar, Inc . Yahoo! - News Network\n\n    The day before the article was published, the stock price of Astrazeneca PLC was 26.40806007385254 and the day after the article was published, the stock price of Astrazeneca PLC was ",
 "expected": "26.688737869262695",
 "date": "2015-09-09",
 "ticker": "AZN",
 "company": "Astrazeneca PLC"
}